Cencora Inc has partnered with Citius Oncology to expand its distribution network and bring LYMPHIR, a FDA-approved immunotherapy, to a wider audience.
Abbott Laboratories exceeded earnings expectations in its second quarter, but its stock price plummeted after the company’s third-quarter earnings forecast fell short of expectations.
Centene Corporation’s stock price has declined significantly due to concerns over Medicaid, the Trump tax bill, and a class action lawsuit alleging securities fraud.
Cigna Group is a dividend stock worth watching, with a proven track record of steady payouts and potential for growth, making it a solid investment opportunity.
Medtronic’s stock performance has been mixed, with both successes and setbacks, raising questions about the company’s ability to drive growth and navigate international regulations.
Quest Diagnostics has introduced a new diagnostic test for the Oropouche virus and partnered with MD Anderson Cancer Center to develop a revolutionary blood test, solidifying its position as a leader in infectious disease detection and cancer resear…
Fisher & Paykel Healthcare Corp is well-positioned to capitalize on the growing global demand for respiratory care devices, driven by an aging population and increasing prevalence of chronic diseases.